145 related articles for article (PubMed ID: 32856609)
21. Racial and Ethnic Disparities in Clinical Trial Enrollment Among Women With Gynecologic Cancer.
Khadraoui W; Meade CE; Backes FJ; Felix AS
JAMA Netw Open; 2023 Dec; 6(12):e2346494. PubMed ID: 38060227
[TBL] [Abstract][Full Text] [Related]
22. Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.
Peres LC; Risch H; Terry KL; Webb PM; Goodman MT; Wu AH; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy ML; Cote ML; Funkhouser E; Moorman PG; Peters ES; Schwartz AG; Terry PD; Manichaikul A; Abbott SE; Camacho F; Jordan SJ; Nagle CM; ; Rossing MA; Doherty JA; Modugno F; Moysich K; Ness R; Berchuck A; Cook L; Le N; Brooks-Wilson A; Sieh W; Whittemore A; McGuire V; Rothstein J; Anton-Culver H; Ziogas A; Pearce CL; Tseng C; Pike M; Schildkraut JM;
Int J Epidemiol; 2018 Apr; 47(2):460-472. PubMed ID: 29211900
[TBL] [Abstract][Full Text] [Related]
23. Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice.
Cheng Y; Huang Z; Liao Q; Yu X; Jiang H; He Y; Yao S; Nie S; Liu L
PLoS One; 2020; 15(6):e0232800. PubMed ID: 32497148
[TBL] [Abstract][Full Text] [Related]
24. Second neoplasms after invasive and borderline ovarian cancer.
Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608
[TBL] [Abstract][Full Text] [Related]
25. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.
Suk R; Mahale P; Sonawane K; Sikora AG; Chhatwal J; Schmeler KM; Sigel K; Cantor SB; Chiao EY; Deshmukh AA
JAMA Netw Open; 2018 Sep; 1(5):e181999. PubMed ID: 30646145
[TBL] [Abstract][Full Text] [Related]
26. Incidence and Survival of Multiple Primary Cancers in US Women With a Gynecologic Cancer.
Corey L; Ruterbusch J; Shore R; Ayoola-Adeola M; Baracy M; Vezina A; Winer I
Front Oncol; 2022; 12():842441. PubMed ID: 35402231
[TBL] [Abstract][Full Text] [Related]
27. Risk of second primary cancer among women in the Kaiser Permanente Breast Cancer Survivors Cohort.
Ramin C; Veiga LHS; Vo JB; Curtis RE; Bodelon C; Aiello Bowles EJ; Buist DSM; Weinmann S; Feigelson HS; Gierach GL; Berrington de Gonzalez A
Breast Cancer Res; 2023 May; 25(1):50. PubMed ID: 37138341
[TBL] [Abstract][Full Text] [Related]
28. Risk of contralateral ovarian cancer in patients undergoing conservative surgery for ovarian cancer.
Guo D; Wang Y; Wang S; Hu J; Chen X; Qu Z; Sui C; He G; Wang C; Liu X
Eur J Surg Oncol; 2022 Sep; 48(9):2053-2060. PubMed ID: 35450756
[TBL] [Abstract][Full Text] [Related]
29. Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S.
Miller BA; Chu KC; Hankey BF; Ries LA
Cancer Causes Control; 2008 Apr; 19(3):227-56. PubMed ID: 18066673
[TBL] [Abstract][Full Text] [Related]
30. Epithelial ovarian cancer and low malignant potential (LMP) tumors associated with a lower incidence of second primary breast cancer.
Hunter MI; Ziogas A; Flores F; Brewster WR
Am J Clin Oncol; 2007 Feb; 30(1):1-7. PubMed ID: 17278887
[TBL] [Abstract][Full Text] [Related]
31. Declining second primary ovarian cancer after first primary breast cancer.
Schonfeld SJ; Berrington de Gonzalez A; Visvanathan K; Pfeiffer RM; Anderson WF
J Clin Oncol; 2013 Feb; 31(6):738-43. PubMed ID: 23284037
[TBL] [Abstract][Full Text] [Related]
32. Risk of Second Primary Female Genital Malignancies in Women with Breast Cancer: a SEER Analysis.
Li Z; Wu Q; Song J; Zhang Y; Zhu S; Sun S
Horm Cancer; 2018 Jun; 9(3):197-204. PubMed ID: 29556910
[TBL] [Abstract][Full Text] [Related]
33. Incidence Trends of Breast Cancer Molecular Subtypes by Age and Race/Ethnicity in the US From 2010 to 2016.
Acheampong T; Kehm RD; Terry MB; Argov EL; Tehranifar P
JAMA Netw Open; 2020 Aug; 3(8):e2013226. PubMed ID: 32804214
[TBL] [Abstract][Full Text] [Related]
34. Merkel cell carcinoma: incidence, mortality, and risk of other cancers.
Kaae J; Hansen AV; Biggar RJ; Boyd HA; Moore PS; Wohlfahrt J; Melbye M
J Natl Cancer Inst; 2010 Jun; 102(11):793-801. PubMed ID: 20424236
[TBL] [Abstract][Full Text] [Related]
35. Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States.
Wu X; Matanoski G; Chen VW; Saraiya M; Coughlin SS; King JB; Tao XG
Cancer; 2008 Nov; 113(10 Suppl):2873-82. PubMed ID: 18980291
[TBL] [Abstract][Full Text] [Related]
36. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
Hisada M; Chen BE; Jaffe ES; Travis LB
J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
[TBL] [Abstract][Full Text] [Related]
37. Racial and ethnic differences in reconstructive surgery for apical vaginal prolapse.
Boyd BAJ; Winkelman WD; Mishra K; Vittinghoff E; Jacoby VL
Am J Obstet Gynecol; 2021 Oct; 225(4):405.e1-405.e7. PubMed ID: 33984303
[TBL] [Abstract][Full Text] [Related]
38. Racial-Ethnic Comparison of Guideline-Adherent Gynecologic Cancer Care in an Equal-Access System.
Eaglehouse YL; Darcy KM; Tian C; Casablanca Y; Shriver CD; Zhu K
Obstet Gynecol; 2021 Apr; 137(4):629-640. PubMed ID: 33706355
[TBL] [Abstract][Full Text] [Related]
39. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States.
Iqbal J; Ginsburg O; Rochon PA; Sun P; Narod SA
JAMA; 2015 Jan; 313(2):165-73. PubMed ID: 25585328
[TBL] [Abstract][Full Text] [Related]
40. Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study.
Fung C; Fossa SD; Milano MT; Oldenburg J; Travis LB
J Clin Oncol; 2013 Oct; 31(30):3807-14. PubMed ID: 24043737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]